S100A6 and S100A2 are the two calcium-binding proteins that are mostly down-regulated in prostate cancer, and the underlying mechanism responsible for it appears to involve hypermethylation of S100A6 and S100A2 [25]. The gene discussed is S100A6; the disease is prostate carcinoma.